首页> 外文期刊>Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions >Is it safe to perform cardiac catheterizations on adults with congenital heart disease in a pediatric catheterization laboratory?
【24h】

Is it safe to perform cardiac catheterizations on adults with congenital heart disease in a pediatric catheterization laboratory?

机译:在儿科导管检查室对患有先天性心脏病的成年人进行心脏导管检查是否安全?

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To determine the complication rate during the catheterization in adults with congenital heart disease (CHD) in a pediatric catheterization laboratory (PCL). BACKGROUND: An increasing number of patients with CHD are surviving into adulthood, with diagnostic and interventional cardiac catheterization being essential for the management of their disease. The complication rate during the catheterization of adults with CHD has not been reported. METHODS: A retrospective chart review was performed on all adult patients (>18 years) with CHD who underwent diagnostic or interventional catheterization in our PCL within the past 8.5 years. RESULTS: A total of 576 procedures were performed on 436 adult patients (median age 26 years). Complex heart disease was present in 387/576 (67%) procedures. An isolated atrial septal defect or patent foramen ovale was present in 115/576 (20%) procedures, and 51/576 (9%) procedures were performed on patients with structurally normal hearts with arrhythmias. Interventional catheterization was performed in 378/576 (66%) procedures. There were complications during 61/576 (10.6%) procedures; 19 were considered major and 42 minor. Major complications were death (1), ventricular fibrillation (1), hypotension requiring inotropes (7), atrial flutter (3), retroperitoneal hematoma, pneumothorax, hemothorax, aortic dissection, renal failure, myocardial ischemia and stent malposition (1 each). The most common minor complications were vascular entry site hematomas and hypotension not requiring inotropes. Procedures performed on patients > or = 45 years of age had a 19% occurrence of complications overall compared with 9% occurrence rate in patients of age < 45 years (P < 0.01). CONCLUSIONS: The complication rate during the catheterization of adults with CHD in a PCL is similar to the complication rate of children with CHD undergoing cardiac catheterization. The older subset of patients are more likely to encounter complications overall. The encountered complications could behandled effectively in the PCL. With screening in place, it is safe to perform cardiac catheterization on most adults with CHD in a PCL.
机译:目的:确定在儿科导管实验室(PCL)中患有先天性心脏病(CHD)的成年人导管插入术中的并发症发生率。背景:越来越多的冠心病患者幸存到成年期,诊断和介入性心脏导管插入术对于控制其疾病至关重要。尚未报道成人冠心病导管插入术中的并发症发生率。方法:对过去8.5年内在我们的PCL中接受过诊断性或介入性导管插入术的所有CHD成人患者(> 18岁)进行了回顾性图表回顾。结果:共对436名成年患者(中位年龄26岁)进行了576例手术。 387/576(67%)的手术中存在复杂的心脏病。 115/576(20%)手术中存在孤立的房间隔缺损或卵圆孔未闭,对结构正常的心律失常患者进行了51/576(9%)手术。介入导管插入以378/576(66%)的程序进行。 61/576(10.6%)手术期间出现并发症; 19人被认为是大学生,42人被认为是未成年人。主要并发症为死亡(1),心室纤颤(1),需要正性肌力的低血压(7),心房扑动(3),腹膜后血肿,气胸,血胸,主动脉夹层,肾衰竭,心肌缺血和支架植入不良(各1种)。最常见的轻微并发症是不需要血管入口的血肿和低血压。在年龄大于或等于45岁的患者中执行的程序总体上发生并发症的比例为19%,而年龄小于45岁的患者中的并发症发生率为9%(P <0.01)。结论:在PCL中成人CHD的导管插入过程中的并发症发生率与接受心脏导管术的CHD儿童的并发症发生率相似。整体而言,年龄较大的患者更有可能遇到并发症。遇到的并发症可以在PCL中得到有效处理。进行适当的筛查后,对大多数PCL中患有CHD的成年人进行心脏导管检查是安全的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号